MedPath

Cephalexin

CEPHALEXIN FOR ORAL SUSPENSION USP

Approved
Approval ID

22ab5dba-bfce-498d-a644-9ca0e343b1cf

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 4, 2010

Manufacturers
FDA

Carlsbad Technology, Inc.

DUNS: 781047246

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Cephalexin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code61442-201
Application NumberANDA065336
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cephalexin
Product Specifications
Route of AdministrationORAL
Effective DateOctober 4, 2010
FDA Product Classification

INGREDIENTS (6)

CephalexinActive
Quantity: 125 mg in 5 mL
Code: OBN7UDS42Y
Classification: ACTIB
Sodium Lauryl SulfateInactive
Code: 368GB5141J
Classification: IACT
SucroseInactive
Code: C151H8M554
Classification: IACT
FD&C Red No. 40Inactive
Code: WZB9127XOA
Classification: IACT
Methylcellulose (25 CPS)Inactive
Code: BI55GG2WLI
Classification: IACT
StrawberryInactive
Code: 4J2TY8Y81V
Classification: IACT

Cephalexin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code61442-202
Application NumberANDA065336
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cephalexin
Product Specifications
Route of AdministrationORAL
Effective DateOctober 4, 2010
FDA Product Classification

INGREDIENTS (6)

Methylcellulose (25 CPS)Inactive
Code: BI55GG2WLI
Classification: IACT
CephalexinActive
Quantity: 250 mg in 5 mL
Code: OBN7UDS42Y
Classification: ACTIB
Sodium Lauryl SulfateInactive
Code: 368GB5141J
Classification: IACT
SucroseInactive
Code: C151H8M554
Classification: IACT
FD&C Red No. 40Inactive
Code: WZB9127XOA
Classification: IACT
StrawberryInactive
Code: 4J2TY8Y81V
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Cephalexin - FDA Drug Approval Details